Endothelin precursors have weak in vitro vasoconstrictor activity but potent in vivo pressor effects, suggesting different mechanisms of action compared to mature endothelin.
Answers are grounded in this paper and cite their sources.
Endothelin precursors warrant mechanistic study in vivo; leaves open relevance to human pressor regulation before any clinical consideration.
Endothelin (ET-21) induced a sustained contraction of rat thoracic aortae (EC50 = 2.65 x 10(-10) M) in vitro, and caused a potent pressor effect in vivo after intravenous administration to rats. In contrast, the precursor deduced from porcine cDNA coding ET-21 (pET-39) had 100-fold less contractile activity in vitro (EC50 = 3.26 x 10(-8) M), and so did the precursor from human cDNA (hET-38) (EC50 = 1.48 x 10(-8) M). However, both pET-39 and hET-38 caused almost the same dose-dependent pressor effects as ET-21 in vivo. After intravenous bolus injection at 1 nmol/kg, ET-21 caused an initial transient drop of the arterial pressure, and then induced a gradual pressor effect. On the other hand, hET-38 caused only a gradual rise of the arterial pressure. There may be different mechanism(s) for ET-21 and hET-38 which induce changes in the arterial pressure in vivo.
No takes yet. Share an insight, caveat, or question.
Kashiwabara et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: